USE OF CDK4/6 INHIBITOR IN COMBINATION WITH IMMUNOTHERAPY IN PREPARING DRUG FOR TREATING LYMPHOMA

摘要

A use of a CDK4/6 inhibitor in combination with immunotherapy in preparing a drug for treating lymphoma. In particular, provided is a use of a compound represented by formula I or a pharmaceutically acceptable salt thereof in combination with an anti-PD-1 antibody or an antigen-binding fragment thereof in preparing a drug for treating lymphoma. The method has good tolerance, controllable toxicity, and enhanced antitumor effect.